Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson
New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…
Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…








